This is the first reported case of acquired TTP developed during conservative treatment of idiopathic MN, with both ADAMTS13 inhibitor and anti-PLA2R antibody positive at the onset of the TTP. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.